Patel Anish sold ELVN
January 9, 2026 · Form 4 insider transaction
Patel Anish sold 243 shares of Enliven Therapeutics, Inc. at $28.50 per share, a transaction worth $6.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
243
Price
$28.50
Total value
$6.9K
InsiderPatel Anish
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 9, 2026
Filing dateJanuary 13, 2026
Shares owned after215,011
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust").; The shares are held by The Patel / Dong Family Trust.